Filing Details
- Accession Number:
- 0001610717-24-000468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-06 16:58:00
- Reporting Period:
- 2024-09-05
- Accepted Time:
- 2024-09-06 16:58:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711404 | Cooper Companies Inc. | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1565801 | G Brian Andrews | C/O The Cooper Companies, Inc. 6101 Bollinger Canyon Road, Suite 500 San Ramon CA 94583 | Evp, Cfo & Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-05 | 13,424 | $32.90 | 20,038 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-09-05 | 11,364 | $43.83 | 31,402 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-05 | 24,788 | $105.90 | 6,614 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-05 | 13,424 | $0.00 | 13,424 | $32.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-05 | 11,364 | $0.00 | 11,364 | $43.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-12-09 | No | 4 | M | Direct | |
| 0 | 2026-12-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 9,296 | Indirect | See footnote |
Footnotes
- Adjusted to reflect Issuer's 4-for-1 stock split effected on February 16, 2024.
- The Form 4/A filed by the Reporting Person on February 15, 2024 understated the amount of securities beneficially owned in Box 5 of Table I by 72 shares. The amount of securities beneficially owned has been adjusted in this Form 4 to correct the aforementioned error in prior filings.
- Includes 93 shares and 181 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on February 1, 2024 and May 1, 2024, respectively.
- Includes 5,196 shares previously reported as indirect holdings.
- Reflects the transfer of 9,296 directly held shares to Andrews Family Trust on August 14, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.585 to $106.36. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Shares held by Andrews Family Trust, of which the Reporting Person and his spouse are co-trustees.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
